CSF3 and cervical squamous intraepithelial neoplasia: Studies reported here aimed to determine whether plinabulin could act as a broad acting anti-CIN agent with multiple chemotherapies of diverse classes, utilizing a mechanism distinct from approved therapies that increase circulating G-CSF.